Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma (ANBL1232)

Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Description:

For complete study information, please view the study on clinicaltrials.gov

Interested in participating?

We are currently recruiting

Full IRB Study Title:

ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma

IRB Study ID:

1021250-1

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...